Company Valuation: Sanofi

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 111,194 112,665 112,549 116,968 100,655 96,600 - -
Change - 1.32% -0.1% 3.93% -13.95% -4.03% - -
Enterprise Value (EV) 1 121,177 119,102 120,342 125,740 111,663 108,304 104,552 101,457
Change - -1.71% 1.04% 4.49% -11.2% -3.01% -3.46% -2.96%
P/E 17.8x 16.7x 20.8x 20.4x 12.9x 13.4x 11.1x 9.5x
PBR 1.62x 1.5x 1.52x 1.51x 1.41x 1.29x 1.22x 1.15x
PEG - 2.07x -1.1x 3.14x 0.3x -2.22x 0.5x 0.6x
Capitalization / Revenue 2.94x 2.62x 2.61x 2.85x 2.31x 1.99x 1.89x 1.79x
EV / Revenue 3.21x 2.77x 2.79x 3.06x 2.56x 2.23x 2.05x 1.88x
EV / EBITDA 9.95x 8.14x 8.44x 9.76x 8.22x 6.97x 6.57x 5.89x
EV / EBIT 11.3x 9.13x 9.5x 11.1x 9.19x 7.92x 7.34x 6.6x
EV / FCF 15x 14x 14.2x 21.1x 13.8x 14x 11.3x 9.84x
FCF Yield 6.68% 7.12% 7.04% 4.74% 7.24% 7.12% 8.86% 10.2%
Dividend per Share 2 3.33 3.56 3.76 3.92 4.12 4.255 4.51 4.776
Rate of return 3.76% 3.96% 4.19% 4.18% 4.98% 5.28% 5.59% 5.92%
EPS 2 4.97 5.37 4.31 4.59 6.4 6.013 7.29 8.483
Distribution rate 67% 66.3% 87.2% 85.4% 64.4% 70.8% 61.9% 56.3%
Net sales 1 37,761 42,997 43,070 41,081 43,626 48,490 51,010 53,939
EBITDA 1 12,183 14,627 14,259 12,889 13,583 15,537 15,921 17,230
EBIT 1 10,714 13,040 12,670 11,343 12,149 13,683 14,235 15,363
Net income 1 6,223 6,720 5,400 5,744 7,813 7,690 8,933 10,377
Net Debt 1 9,983 6,437 7,793 8,772 11,008 11,704 7,952 4,856
Reference price 2 88.58 89.84 89.76 93.74 82.72 80.63 80.63 80.63
Nbr of stocks (in thousands) 1,255,293 1,254,060 1,253,891 1,247,793 1,216,810 1,198,069 - -
Announcement Date 4/2/22 3/2/23 1/2/24 30/1/25 29/1/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
13.41x2.23x7.02x5.28% 108B
41.24x13.98x31x0.48% 1,257B
39.6x6.65x18.71x1.97% 651B
36.2x8.44x17.42x2.4% 510B
21.41x5.2x12.95x2.52% 388B
98.19x6.02x25.62x2.29% 366B
22.92x5.89x14.21x2.72% 303B
24.43x4.89x13.76x1.79% 288B
29.52x7.52x13.46x2.17% 252B
-40.78x7.43x46.67x1.94% 211B
Average 28.62x 6.83x 20.08x 2.36% 433.49B
Weighted average by Cap. 35.66x 8.61x 22.31x 1.8%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Sanofi

Historical PBR trend

Valuation ratios - PBR - Sanofi

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Sanofi

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Sanofi


Year-on-year evolution of the Yield

Valuation ratios - Yield - Sanofi